Shares of Bangalore-based Astrazeneca Pharma were locked at upper circuit of 20% on Monday after the drugmaker said its board would meet on Wednesday to discuss the delisting proposal.
In a BSE release on Monday, the drugmaker notified the exchanges that the Sweden-based promoter AstraZeneca Pharmaceuticals AB has proposed to make a voluntary delisting offer to the public shareholders of the company. Currently, AstraZeneca Pharmaceuticals AB holds 75% stake in its Indian subsidiary.
Also Read
Chef turned woman into ?200-a-night prostitute
World’s fastest bowler: Morne Morkel at a humongous 173.9 kmph at IPL 2013, but Hawk-Eye was not looking
Shraddha Kapoor on money, sex and Rs 100 crore club
Our world was hotter 1,000 years ago
